Greg Keenan

Greg Keenan

Former Chief Medical OfficeratAurinia Pharmaceuticals· In proxies 2022–2025

Pay in FY2025+34% from the year before · Aurinia Pharmaceuticals stock +77.6% the same year

Greg Keenan was paid $1.8M in FY2025 (Dec), up 34%. Aurinia Pharmaceuticals stock rose 77.6% that year.

Pay$100 in the stock at the end of FY21 → $70
Pay is from the Summary Compensation Table of each Aurinia Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aurinia PharmaceuticalsPublic company · 4 yr
    • Former Chief Medical Officer2022 – Present · 4 yrStock in role -27%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?